Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.
Publication
, Journal Article
Cabot, CF; Anderson, KM; Tcheng, JE; Lincoff, AM
Published in: AMERICAN JOURNAL OF CARDIOLOGY
September 22, 1999
Duke Scholars
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 22, 1999
Volume
84
Issue
6A
Start / End Page
71P / 71P
Publisher
EXCERPTA MEDICA INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Cabot, C. F., Anderson, K. M., Tcheng, J. E., & Lincoff, A. M. (1999). Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention. AMERICAN JOURNAL OF CARDIOLOGY, 84(6A), 71P-71P.
Cabot, C. F., K. M. Anderson, J. E. Tcheng, and A. M. Lincoff. “Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.” AMERICAN JOURNAL OF CARDIOLOGY 84, no. 6A (September 22, 1999): 71P-71P.
Cabot CF, Anderson KM, Tcheng JE, Lincoff AM. Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention. AMERICAN JOURNAL OF CARDIOLOGY. 1999 Sep 22;84(6A):71P-71P.
Cabot, C. F., et al. “Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.” AMERICAN JOURNAL OF CARDIOLOGY, vol. 84, no. 6A, EXCERPTA MEDICA INC, Sept. 1999, pp. 71P-71P.
Cabot CF, Anderson KM, Tcheng JE, Lincoff AM. Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention. AMERICAN JOURNAL OF CARDIOLOGY. EXCERPTA MEDICA INC; 1999 Sep 22;84(6A):71P-71P.
Published In
AMERICAN JOURNAL OF CARDIOLOGY
ISSN
0002-9149
Publication Date
September 22, 1999
Volume
84
Issue
6A
Start / End Page
71P / 71P
Publisher
EXCERPTA MEDICA INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology